187 related articles for article (PubMed ID: 31589747)
1. Comparative Analysis of Cytokines of Tumor Cell Lines, Malignant and Benign Effusions Around Breast Implants.
Kadin ME; Morgan J; Kouttab N; Xu H; Adams WP; Glicksman C; McGuire P; Sieber D; Epstein AL; Miranda RN; Clemens MW
Aesthet Surg J; 2020 May; 40(6):630-637. PubMed ID: 31589747
[TBL] [Abstract][Full Text] [Related]
2. Granzyme B Is a Biomarker for Suspicion of Malignant Seromas Around Breast Implants.
Kadin ME; Morgan J; Xu H; Glicksman C; Sieber D; Adams WP; McGuire P; Clemens MW; Thakur A; Lum LG
Aesthet Surg J; 2021 Nov; 41(12):1359-1364. PubMed ID: 33165542
[TBL] [Abstract][Full Text] [Related]
3. What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Kadin ME
Aesthet Surg J; 2019 Jan; 39(Suppl_1):S28-S35. PubMed ID: 30715174
[TBL] [Abstract][Full Text] [Related]
4. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of breast implant associated anaplastic large cell lymphoma by analysis of cytokines in peri-implant seromas.
Hu H; Shklovskaya E; Deva A; Xu H; Fan K; Brosamer K; Willson R; Khan I; Sinha M; Kadin ME
Am J Hematol; 2023 Nov; 98(11):E312-E314. PubMed ID: 37646570
[TBL] [Abstract][Full Text] [Related]
6. Clinical Implications and Management of Non-BIA-ALCL Breast Implant Capsular Pathology.
Vorstenbosch J; Chu JJ; Ariyan CE; McCarthy CM; Disa JJ; Nelson JA
Plast Reconstr Surg; 2023 Jan; 151(1):20e-30e. PubMed ID: 36194076
[TBL] [Abstract][Full Text] [Related]
7. CD30 Lateral Flow and Enzyme-Linked Immunosorbent Assays for Detection of BIA-ALCL: A Pilot Study.
Zeyl VG; Xu H; Khan I; Machan JT; Clemens MW; Hu H; Deva A; Glicksman C; McGuire P; Adams WP; Sieber D; Sinha M; Kadin ME
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958303
[TBL] [Abstract][Full Text] [Related]
8. IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas.
Di Napoli A; Greco D; Scafetta G; Ascenzi F; Gulino A; Aurisicchio L; Santanelli Di Pompeo F; Bonifacino A; Giarnieri E; Morgan J; Mancini R; Kadin ME
Cancer Immunol Immunother; 2021 May; 70(5):1379-1392. PubMed ID: 33146828
[TBL] [Abstract][Full Text] [Related]
9. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
Kadin ME; Adams WP; Inghirami G; Di Napoli A
Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
[TBL] [Abstract][Full Text] [Related]
10. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
[TBL] [Abstract][Full Text] [Related]
11. What's Your Micromort? A Patient-Oriented Analysis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Sieber DA; Adams WP
Aesthet Surg J; 2017 Sep; 37(8):887-891. PubMed ID: 29036945
[TBL] [Abstract][Full Text] [Related]
12. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Turner SD; Inghirami G; Miranda RN; Kadin ME
Am J Pathol; 2020 Jan; 190(1):2-10. PubMed ID: 31610171
[TBL] [Abstract][Full Text] [Related]
13. Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman.
de Boer M; van der Sluis WB; de Boer JP; Overbeek LIH; van Leeuwen FE; Rakhorst HA; van der Hulst RRWJ; Hijmering NJ; Bouman MB; de Jong D
Aesthet Surg J; 2017 Sep; 37(8):NP83-NP87. PubMed ID: 29036941
[TBL] [Abstract][Full Text] [Related]
14. Use of flow cytometry and cytology to differentiate breast implant-associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients.
De Azambuja AP; Gevert F; Oliveira RM; Sebastião AP; Groth AK
Cytometry B Clin Cytom; 2022 Jul; 102(4):312-316. PubMed ID: 34791787
[TBL] [Abstract][Full Text] [Related]
15. Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population.
Tevis SE; Hunt KK; Miranda RN; Lange C; Butler CE; Clemens MW
Aesthet Surg J; 2019 Sep; 39(10):1065-1070. PubMed ID: 30715139
[TBL] [Abstract][Full Text] [Related]
16. Breast implant-associated anaplastic large cell lymphoma and effusions: A review with emphasis on the role of cytopathology.
Julien LA; Michel RP; Auger M
Cancer Cytopathol; 2020 Jul; 128(7):440-451. PubMed ID: 31899606
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological Profile in Portugal of Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Cross-Sectional Study.
Cunha A; Horta R; Barreiro D
Acta Med Port; 2021 Aug; 34(9):572-579. PubMed ID: 33512315
[TBL] [Abstract][Full Text] [Related]
18. EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants.
Cardoso MJ; Wyld L; Rubio IT; Leidenius M; Curigliano G; Cutuli B; Marotti L; Biganzoli L
Breast; 2019 Apr; 44():90-93. PubMed ID: 30703669
[TBL] [Abstract][Full Text] [Related]
19. [How to manage late periprosthetic fluid collections (seromas) in patients with breast implants?].
Garnier L; Tourasse C; Frobert P; Vaucher R; Perez S; Delay E
Ann Chir Plast Esthet; 2023 Jan; 68(1):66-76. PubMed ID: 36266214
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Deva A; Xu H; Morgan J; Khare P; MacLeod RA; Van Natta BW; Adams WP; Brody GS; Epstein AL
Aesthet Surg J; 2016 Jul; 36(7):773-81. PubMed ID: 26979456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
